What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Bacteria
Federico Perez focuses on Microbiology, Klebsiella pneumoniae, Colistin, Internal medicine and Antibiotics.
His biological study spans a wide range of topics, including Molecular epidemiology, Acinetobacter baumannii and Infection control.
His biological study deals with issues like Carbapenem, which deal with fields such as Mortality rate.
In his research, Fosfomycin is intimately related to Tigecycline, which falls under the overarching field of Colistin.
The study incorporates disciplines such as Pseudomonas aeruginosa, Gastroenterology and Pediatrics in addition to Internal medicine.
His research in Antibiotics tackles topics such as Intensive care medicine which are related to areas like Klebsiella species, Hospitalized patients, Pharmacology and Antimicrobial chemotherapy.
His most cited work include:
- Global Challenge of Multidrug-Resistant Acinetobacter baumannii (931 citations)
- THE CONTINUING CHALLENGE OF ESBLS (237 citations)
- Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae (234 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Microbiology, Klebsiella pneumoniae, Internal medicine, Antibiotics and Carbapenem-resistant enterobacteriaceae.
His Microbiology study incorporates themes from Pseudomonas aeruginosa and Acinetobacter baumannii.
His Klebsiella pneumoniae study integrates concerns from other disciplines, such as Tigecycline, Intensive care medicine, Colistin and Meropenem.
His work in Internal medicine covers topics such as Bacteremia which are related to areas like Incidence and Meningitis.
His Antibiotics research includes elements of Efflux and Virology.
His Carbapenem-resistant enterobacteriaceae research integrates issues from Carbapenem resistant Klebsiella pneumoniae, Klebsiella, Epidemiology and Confidence interval.
He most often published in these fields:
- Microbiology (68.75%)
- Klebsiella pneumoniae (58.04%)
- Internal medicine (39.29%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (68.75%)
- Internal medicine (39.29%)
- Antibiotics (24.11%)
In recent papers he was focusing on the following fields of study:
Federico Perez spends much of his time researching Microbiology, Internal medicine, Antibiotics, Klebsiella pneumoniae and Drug resistance.
His work on Multiple drug resistance, Colistin and Bacteremia as part of his general Microbiology study is frequently connected to Chemistry, thereby bridging the divide between different branches of science.
His work deals with themes such as Tazobactam, Osteomyelitis and Ceftolozane, which intersect with Internal medicine.
The study incorporates disciplines such as Siderophore, Emergency medicine and Intensive care medicine in addition to Antibiotics.
Federico Perez has researched Klebsiella pneumoniae in several fields, including Antimicrobial, Therapeutic drug monitoring and Aztreonam.
His work carried out in the field of Drug resistance brings together such families of science as Veterinary medicine, Antibiotic resistance, Multilocus sequence typing and Polymyxin.
Between 2018 and 2021, his most popular works were:
- Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa (34 citations)
- Polymyxins: To Combine or Not to Combine? (16 citations)
- Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV (16 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Bacteria
Microbiology, Ceftazidime/avibactam, Klebsiella pneumoniae, Drug resistance and Antibiotic resistance are his primary areas of study.
His Microbiology study focuses mostly on Multiple drug resistance and Bacteremia.
His Klebsiella pneumoniae study frequently draws parallels with other fields, such as Therapeutic drug monitoring.
His studies in Drug resistance integrate themes in fields like Veterinary medicine and Polymyxin.
He has included themes like Transformation, Enterobacteriaceae and Multilocus sequence typing in his Antibiotic resistance study.
His work deals with themes such as Internal medicine, Tazobactam and Empiric therapy, which intersect with Ceftazidime.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
